vs
Amneal Pharmaceuticals, Inc.（AMRX）与Gaming & Leisure Properties, Inc.（GLPI）财务数据对比。点击上方公司名可切换其他公司
Amneal Pharmaceuticals, Inc.的季度营收约是Gaming & Leisure Properties, Inc.的1.7倍（$722.5M vs $420.0M），Gaming & Leisure Properties, Inc.净利率更高（57.0% vs 10.8%，领先46.2%），Gaming & Leisure Properties, Inc.同比增速更快（6.3% vs 3.9%），过去两年Gaming & Leisure Properties, Inc.的营收复合增速更高（5.0% vs 1.5%）
Amneal Pharmaceuticals是一家美国上市制药企业，核心业务涵盖仿制药及专科药物的研发、生产与分销，总部位于新泽西州布里奇沃特，是美国规模最大的仿制药生产商之一。
博彩与休闲地产公司（GLPI）是一家专注于赌场物业的房地产投资信托（REIT），总部位于宾夕法尼亚州怀奥米辛。公司于2013年11月从宾州国民娱乐分拆成立，目前持有62处赌场物业，全部对外出租给其他企业运营。
AMRX vs GLPI — 直观对比
营收规模更大
AMRX
是对方的1.7倍
$420.0M
营收增速更快
GLPI
高出2.4%
3.9%
净利率更高
GLPI
高出46.2%
10.8%
两年增速更快
GLPI
近两年复合增速
1.5%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $722.5M | $420.0M |
| 净利润 | $78.0M | $239.4M |
| 毛利率 | 44.3% | — |
| 营业利润率 | 19.6% | 79.4% |
| 净利率 | 10.8% | 57.0% |
| 营收同比 | 3.9% | 6.3% |
| 净利润同比 | 410.5% | 40.5% |
| 每股收益（稀释后） | $0.19 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRXGLPI
| Q1 26 | $722.5M | $420.0M | ||
| Q4 25 | $814.3M | $407.0M | ||
| Q3 25 | $784.5M | $397.6M | ||
| Q2 25 | $724.5M | $394.9M | ||
| Q1 25 | $695.4M | $395.2M | ||
| Q4 24 | $730.5M | $389.6M | ||
| Q3 24 | $702.5M | $385.3M | ||
| Q2 24 | $701.8M | $380.6M |
净利润AMRXGLPI
| Q1 26 | $78.0M | $239.4M | ||
| Q4 25 | $35.1M | $275.4M | ||
| Q3 25 | $2.4M | $241.2M | ||
| Q2 25 | $22.4M | $151.4M | ||
| Q1 25 | $12.2M | $165.2M | ||
| Q4 24 | $-31.1M | $223.6M | ||
| Q3 24 | $-156.0K | $184.7M | ||
| Q2 24 | $6.0M | $208.3M |
毛利率AMRXGLPI
| Q1 26 | 44.3% | — | ||
| Q4 25 | 36.5% | — | ||
| Q3 25 | 34.9% | — | ||
| Q2 25 | 39.5% | — | ||
| Q1 25 | 36.8% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 38.4% | — | ||
| Q2 24 | 35.6% | — |
营业利润率AMRXGLPI
| Q1 26 | 19.6% | 79.4% | ||
| Q4 25 | 13.8% | 89.3% | ||
| Q3 25 | 9.0% | 84.8% | ||
| Q2 25 | 15.4% | 61.3% | ||
| Q1 25 | 14.4% | 65.5% | ||
| Q4 24 | 10.4% | 79.1% | ||
| Q3 24 | 12.6% | 70.4% | ||
| Q2 24 | 13.6% | 77.1% |
净利率AMRXGLPI
| Q1 26 | 10.8% | 57.0% | ||
| Q4 25 | 4.3% | 67.6% | ||
| Q3 25 | 0.3% | 60.7% | ||
| Q2 25 | 3.1% | 38.4% | ||
| Q1 25 | 1.8% | 41.8% | ||
| Q4 24 | -4.3% | 57.4% | ||
| Q3 24 | -0.0% | 47.9% | ||
| Q2 24 | 0.9% | 54.7% |
每股收益（稀释后）AMRXGLPI
| Q1 26 | $0.19 | — | ||
| Q4 25 | $0.10 | $0.96 | ||
| Q3 25 | $0.01 | $0.85 | ||
| Q2 25 | $0.07 | $0.54 | ||
| Q1 25 | $0.04 | $0.60 | ||
| Q4 24 | $-0.10 | $0.79 | ||
| Q3 24 | $0.00 | $0.67 | ||
| Q2 24 | $0.02 | $0.77 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $197.7M | $274.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $5.0B |
| 总资产 | $3.5B | $13.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRXGLPI
| Q1 26 | $197.7M | $274.5M | ||
| Q4 25 | $282.0M | — | ||
| Q3 25 | $201.2M | — | ||
| Q2 25 | $71.5M | — | ||
| Q1 25 | $59.2M | — | ||
| Q4 24 | $110.6M | $560.8M | ||
| Q3 24 | $74.0M | $560.8M | ||
| Q2 24 | $43.8M | $560.8M |
总债务AMRXGLPI
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | $7.2B | ||
| Q3 25 | $2.6B | $7.2B | ||
| Q2 25 | $2.2B | $6.9B | ||
| Q1 25 | $2.2B | $6.9B | ||
| Q4 24 | $2.4B | $7.7B | ||
| Q3 24 | $2.4B | $7.4B | ||
| Q2 24 | $2.4B | $6.6B |
股东权益AMRXGLPI
| Q1 26 | — | $5.0B | ||
| Q4 25 | $-70.8M | $4.6B | ||
| Q3 25 | $-109.5M | $4.6B | ||
| Q2 25 | $-112.1M | $4.6B | ||
| Q1 25 | $-131.7M | $4.2B | ||
| Q4 24 | $-109.3M | $4.3B | ||
| Q3 24 | $-93.4M | $4.3B | ||
| Q2 24 | $-57.5M | $4.1B |
总资产AMRXGLPI
| Q1 26 | $3.5B | $13.8B | ||
| Q4 25 | $3.7B | $12.9B | ||
| Q3 25 | $3.6B | $12.8B | ||
| Q2 25 | $3.4B | $12.5B | ||
| Q1 25 | $3.4B | $12.1B | ||
| Q4 24 | $3.5B | $13.1B | ||
| Q3 24 | $3.5B | $12.7B | ||
| Q2 24 | $3.5B | $11.8B |
负债/权益比AMRXGLPI
| Q1 26 | — | — | ||
| Q4 25 | — | 1.56× | ||
| Q3 25 | — | 1.57× | ||
| Q2 25 | — | 1.51× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.81× | ||
| Q3 24 | — | 1.74× | ||
| Q2 24 | — | 1.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
